Log in to your account:
Biogen (BIIB) PT Lowered to $236 at Guggenheim
March 22, 2019 11:10 AM
Guggenheim analyst Yatin Suneja lowered the price target on Biogen (NASDAQ: BIIB) to $236.00 (from $325.00) while maintaining a Neutral ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Analyst PT Change
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
March 25, 2019 7:49 AM